Sex differences in brain epigenetics

Epigenomics

Volumn 2, Issue 6, 2010, Pages 807-821

  Menger, Yannick ^a   Bettscheider, Marc ^a   Murgatroyd, Chris ^a   Spengler, Dietmar ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

brain; epigenetic therapy; epigenetics; mental disease; sex differences

Indexed keywords

ANDROGEN; ESTROGEN; PROGESTERONE; STEROID RECEPTOR; VALPROIC ACID;

AGING; BIPOLAR DISORDER; BRAIN DISEASE; DNA METHYLATION; DRUG INHIBITION; EPIGENETICS; EPILEPSY; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; PHENOTYPE; POSTNATAL DEVELOPMENT; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEX DIFFERENCE; SEXUAL DEVELOPMENT;

BRAIN; DRUG THERAPY; EPIGENESIS, GENETIC; EPIGENOMICS; FEMALE; GONADAL STEROID HORMONES; GONADS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PHENOTYPE; RECEPTORS, STEROID; SEX DIFFERENTIATION; SEX FACTORS;

EID: 78650506507     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.10.60     Document Type: Review

References (98)

1. Ma X, Ezzeldin HH, Diasio RB: Histone deacetylase inhibitors: current status and overview of recent clinical trials. Drugs 69(14), 1911-1934 (2009)
2. Zucker I, Beery AK: Males still dominate animal studies. Nature 465(7299), 690 (2010).
3. Kim AM, Tingen CM, Woodruff TK: Sex bias in trials and treatment must end. Nature 465(7299), 688-689 (2010).
4. Holden C: Women abound in NIH trials. Science 322(5899), 219 (2008).
5. Gillies GE, McArthur S: Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol. Rev. 62(2), 155-198 (2010).
6. Anderson GD: Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J. Womens Health (Larchmt.) 14(1), 19-29 (2005).
7. Arnold AP, Xu J, Grisham W, Chen X, Kim YH, Itoh Y: Minireview: sex chromosomes and brain sexual differentiation. Endocrinology 145(3), 1057-1062 (2004).
8. Negri-Cesi P, Colciago A, Pravettoni A, Casati L, Conti L, Celotti F: Sexual differentiation of the rodent hypothalamus: hormonal and environmental influences. J. Steroid Biochem. Mol. Biol. 109(3-5), 294-299 (2008).
9. Roselli CE, Abdelgadir SE, Resko JA: Regulation of aromatase gene expression in the adult rat brain. Brain Res. Bull. 44(4), 351-357 (1997).
10. Perez SE, Chen EY, Mufson EJ: Distribution of estrogen receptor a and b immunoreactive profiles in the postnatal rat brain. Brain Res. Dev. Brain Res. 145(1), 117-139 (2003).
11. Wilson ME, Rosewell KL, Kashon ML, Shughrue PJ, Merchenthaler I, Wise PM: Age differentially influences estrogen receptor-a (ERa) and estrogen receptor-b (ERb) gene expression in specific regions of the rat brain. Mech. Ageing Dev. 123(6), 593-601 (2002).
12. Kühnemann S, Brown TJ, Hochberg RB, MacLusky NJ: Sex differences in the development of estrogen receptors in the rat brain. Horm. Behav. 28(4), 483-491 (1994).
13. Kudwa AE, Michopoulos V, Gatewood JD, Rissman EF: Roles of estrogen receptors a and b in differentiation of mouse sexual behavior. Neuroscience 138(3), 921-928 (2006).
14. Negri-Cesi P, Poletti A, Celotti F: Metabolism of steroids in the brain: a new insight into the role of 5a-reductase and aromatase in brain differentiation and functions. J. Steroid Biochem. Mol. Biol. 58(5-6), 455-466 (1996).
15. Amateau SK, Alt JJ, Stamps CL, McCarthy MM: Brain estradiol content in newborn rats: sex differences, regional heterogeneity, and possible de novo synthesis by the female telencephalon. Endocrinology 145(6), 2906-2917 (2004).
16. Poletti A, Negri-Cesi P, Melcangi RC, Colciago A, Martini L, Celotti F: Expression of androgen-activating enzymes in cultured cells of developing rat brain. J. Neurochem. 68(3), 1298-1303 (1997).
17. Ribeiro CM, Pereira OC: 5a-reductase 2 inhibition impairs brain defeminization of male rats: reproductive aspects. Pharmacol. Biochem. Behav. 82(1), 228-235 (2005).
18. Goto K, Koizumi K, Ohta Y et al.: Evaluation of general behavior, memory, learning performance, and brain sexual differentiation in F1 offspring males of rats treated with flutamide during late gestation. J. Toxicol. Sci. 30(3), 249-259 (2005).
19. Sato T, Matsumoto T, Kawano H et al.: Brain masculinization requires androgen receptor function. Proc. Natl Acad. Sci. USA 101(6), 1673-1678 (2004). (Pubitemid 38234213)
20. Quadros PS, Wagner CK: Regulation of progesterone receptor expression by estradiol is dependent on age, sex and region in the rat brain. Endocrinology 149(6), 3054-3061 (2008).
21. Weisz J, Ward IL: Plasma testosterone and progesterone titers of pregnant rats, their male and female fetuses, and neonatal offspring. Endocrinology 106(1), 306-316 (1980).
22. Quadros PS, Pfau JL, Goldstein AY, De Vries GJ, Wagner CK: Sex differences in progesterone receptor expression: a potential mechanism for estradiol-mediated sexual differentiation. Endocrinology 143(10), 3727-3739 (2002).
23. Wagner CK: Progesterone receptors and neural development: a gap between bench and bedside? Endocrinology 149(6), 2743-2749 (2008).
24. McCarthy MM, Auger AP, Bale TL et al.: The epigenetics of sex differences in the brain. J. Neurosci. 29(41), 12815-12823 (2009).
25. Jaenisch R, Bird A: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33(Suppl.), 245-254 (2003).
26. Reik W: Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447(7143), 425-432 (2007).
27. Cardoso MC, Leonhardt H: DNA methyltransferase is actively retained in the cytoplasm during early development. J. Cell Biol. 147(1), 25-32 (1999).
28. Okano M, Bell DW, Haber DA, Li E: DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99(3), 247-257 (1999).
29. Jrgensen HF, Bird A: MeCP2 and other methyl-CpG binding proteins. Ment. Retard. Dev. Disabil. Res. Rev. 8(2), 87-93 (2002).
30. Fuks F, Burgers WA, Godin N, Kasai M, Kouzarides T: DNMT3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J. 20(10), 2536-2544 (2001).
31. Westberry JM, Trout AL, Wilson ME: Epigenetic regulation of estrogen receptor a gene expression in the mouse cortex during early postnatal development. Endocrinology 151(2), 731-740 (2010).
32. Schwarz JM, Nugent BM, McCarthy MM: Developmental and hormone-induced epigenetic changes to estrogen and progesterone receptor genes in brain are dynamic across the life span. Endocrinology 151(10), 4871-4881 (2010).
33. Kurian JR, Olesen KM, Auger AP: Sex differences in epigenetic regulation of the estrogen receptor-a promoter within the developing preoptic area. Endocrinology 151(5), 2297-2305 (2010).
34. Wagner CK, Pfau JL, De Vries GJ, Merchenthaler IJ: Sex differences in progesterone receptor immunoreactivity in neonatal mouse brain depend on estrogen receptor expression. J. Neurobiol. 47, 176-182 (2001).
35. Nugent BM, Schwarz JM, McCarthy MM: Hormonally mediated epigenetic changes to steroid receptors in the developing brain: Implications for sexual differentiation. Horm. Behav. DOI: 10.1016/j.yhbeh.2010.08.009 (2010) (Epub ahead of print).
36. Kumar RC, Thakur MK: Androgen receptor mRNA is inversely regulated by testosterone and estradiol in adult mouse brain. Neurobiol. Aging 25(7), 925-933 (2004).
37. Xiao Y, Word B, Starlard-Davenport A, Haefele A, Lyn-Cook BD, Hammons G: Age and gender affect DNMT3a and DNMT3b expression in human liver. Cell. Biol. Toxicol. 24(3), 265-272 (2008).
38. Galetzka D, Weis E, Tralau T, Seidmann L, Haaf T: Sex-specific windows for high mRNA expression of DNA methyltransferases 1 and 3a and methyl-CpG-binding domain proteins 2 and 4 in human fetal gonads. Mol. Reprod. Dev. 74(2), 233-241 (2007)
39. Yamagata Y, Asada H, Tamura I: DNA methyltransferase expression in the human endometrium: down-regulation by progesterone and estrogen. Hum. Reprod. 24(5), 1126-1132 (2009).
40. Zhao Z, Fan L, Frick KM: Epigenetic alterations regulate estradiol-induced enhancement of memory consolidation. Proc. Natl Acad. Sci. USA 107(12), 5605-5610 (2010).
41. McCarthy MM, Auger AP, Bale TL et al.: The epigenetics of sex differences in the brain. J. Neurosci. 29(41), 12815-12823 (2009).
42. Pathak S, DSouza R, Ankolkar M, Gaonkar R, Balasinor NH: Potential role of estrogen in regulation of the insulin-like growth factor2-H19 locus in the rat testis. Mol. Cell. Endocrinol. 314(1), 110-117 (2010).
43. Kurian JR, Forbes-Lorman RM, Auger AP: Sex difference in MeCP2 expression during a critical period of rat brain development. Epigenetics 2(3), 173-178 (2007).
44. Kurian JR, Bychowski ME, Forbes-Lorman RM, Auger CJ, Auger AP: MeCP2 organizes juvenile social behavior in a sex-specific manner. J. Neurosci. 28(28), 7137-7142 (2008).
45. Koh SS, Chen D, Lee YH, Stallcup MR: Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J. Biol. Chem. 276(2), 1089-1098 (2001).
46. Bousios S, Karandrea D, Kittas C, Kitraki E: Effects of gender and stress on the regulation of steroid receptor coactivator-1 expression in the rat brain and pituitary. J. Steroid Biochem. Mol. Biol. 78(5), 401-407 (2001).
47. Auger AP, Perrot-Sinal TS, Auger CJ, Ekas LA, Tetel MJ, Mccarthy MM: Expression of the nuclear receptor coactivator, cAMP response element-binding protein, is sexually dimorphic and modulates sexual differentiation of neonatal rat brain. Endocrinology 143(8), 3009-3016 (2002).
48. Jessen HM, Kolodkin MH, Bychowski ME, Auger CJ, Auger AP: The nuclear receptor corepressor has organizational effects within the developing amygdala on juvenile social play and anxiety-like behavior. Endocrinology 151(3), 1212-1220 (2010).
49. Auger AP, Tetel MJ, McCarthy MM: Steroid receptor coactivator-1 (SRC-1) mediates the development of sex-specific brain morphology and behavior. Proc. Natl Acad. Sci. USA 97(13), 7551-7555 (2000).
50. Rosenfeld MG, Lunyak VV, Glass CK: Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20(11), 1405-1428 (2006).
51. Hsieh J, Gage FH: Chromatin remodeling in neural development and plasticity. Curr. Opin. Cell Biol. 17(6), 664-671 (2005).
52. Gagnidze K, Weil ZM, Pfaff DW: Histone modifications proposed to regulate sexual differentiation of brain and behavior. Bioessays DOI: 10.1002/bies.201000064 (2010) (Epub ahead of print).
53. Tsai HW, Grant PA, Rissman EF: Sex differences in histone modifications in the neonatal mouse brain. Epigenetics 4(1), 47-53 (2009).
54. Murray EK, Hien A, De Vries GJ, Forger NG: Epigenetic control of sexual differentiation of the bed nucleus of the stria terminalis. Endocrinology 150(9), 4241-4247 (2009).
55. Baum MJ: New evidence that an epigenetic mechanism mediates testosterone-dependent brain masculinization. Endocrinology 150(9), 3980-3982 (2009).
56. Jensen LR, Amende M, Gurok U: Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. Am. J. Hum. Genet. 76(2), 227-236 (2005).
57. Xu J, Deng X, Watkins R, Disteche CM: Sex-specific differences in expression of histone demethylases Utx and Uty in mouse brain and neurons. J. Neurosci. 28(17), 4521-4527 (2008).
58. Xu J, Andreassi M: Reversible histone methylation regulates brain gene expression and behavior. Horm. Behav. DOI: 10.1016/j.yhbeh.2010.08.019 (2010) (Epub ahead of print).
59. van Haaften G, Dalgliesh GL, Davies H: Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat. Genet. 41(5), 521-523 (2009).
60. Bateson P, Barker D, Clutton-Brock T et al.: Developmental plasticity and human health. Nature 430(6998), 419-421 (2004).
61. Gluckman PD, Hanson MA, Bateson P et al.: Towards a new developmental synthesis: adaptive developmental plasticity and human disease. Lancet 373(9675), 1654-1657 (2009).
62. Ke X, Lei Q, James SJ et al.: Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats. Physiol. Genomics 25(1), 16-28 (2006).
63. Jarvis S, Glinianaia SV, Arnaud C et al.: Case gender and severity in cerebral palsy varies with intrauterine growth. Arch. Dis. Child. 90(5), 474-479 (2005).
64. Stevenson DK, Verter J, Fanaroff AA et al.: Sex differences in outcomes of very low birthweight infants: the newborn male disadvantage. Arch. Dis. Child. Fetal Neonatal Ed. 83(3), F182-F185 (2000).
65. Champagne FA, Weaver IC, Diorio J, Dymov S, Szyf M, Meaney MJ: Maternal care associated with methylation of the estrogen receptor-a1b promoter and estrogen receptor-a expression in the medial preoptic area of female offspring. Endocrinology 147(6), 2909-2915 (2006).
66. Murgatroyd C, Patchev AV, Wu Y et al.: Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat. Neurosci. 12(12), 1559-1566 (2009).
67. Binder EB, Künzel HE, Nickel T et al.: HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients. Psychoneuroendocrinology 34(1), 99-109 (2009).
68. Nolen-Hoeksema S, Girgus JS: The emergence of gender differences in depression during adolescence. Psychol. Bull. 115(3), 424-443 (1994).
69. Swarr AE, Richards MH: Longitudinal effects of adolescent girls pubertal development, perceptions of pubertal timing, and parental relations of eating problems. Dev. Psychol. 32, 636-646 (1996).
70. Ge X, Conger RD, Elder GH: Pubertal transition, stressful life events, and the emergence of gender differences in adolescent depressive symptoms. Dev. Psychol. 37, 404-417 (2001).
71. Mill J, Tang T, Kaminsky Z et al.: Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am. J. Hum. Genet. 82(3), 696-711 (2008).
72. Akbarian S, Kim JJ, Potkin SG et al.: Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 52(4), 258-266 (1995).
73. Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes FM: Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch. Gen. Psychiatry 59(6), 521-529 (2002).
74. Huang HS, Matevossian A, Whittle C et al.: Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. J. Neurosci. 27(42), 11254-11262 (2007).
75. Westberry JM, Prewitt AK, Wilson ME: Epigenetic regulation of the estrogen receptor a promoter in the cerebral cortex following ischemia in male and female rats. Neuroscience 152(4), 982-989 (2008).
76. Seeman MV: Psychopathology in women and men: focus on female hormones. Am. J. Psychiatry 154(12), 1641-1647 (1997).
77. Mani ST, Thakur MK: In the cerebral cortex of female and male mice, amyloid precursor protein (APP) promoter methylation is higher in females and differentially regulated by sex steroids. Brain Res. 1067(1), 43-47 (2006).
78. Zhou L, Cheng X, Connolly BA, Dickman MJ, Hurd PJ, Hornby DP: Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases. J. Mol. Biol. 321(4), 591-599 (2002).
79. Drummond DC, Noble CO, Kirpotin DB, Guo Z, Scott GK, Benz CC: Clinical development of histone deacetylase inhibitors as anticancer agents. Annu. Rev. Pharmacol. Toxicol. 45, 495-528 (2005).
80. McGowan PO, Meaney MJ, Szyf M: Diet and the epigenetic (re)programming of phenotypic differences in behavior. Brain Res. 1237, 12-24 (2008).
81. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ: Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 9(4), 519-525 (2006).
82. Schroeder FA, Lin CL, Crusio WE, Akbarian S: Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol. Psychiatry 62(1), 55-64 (2007).
83. Covington HE 3rd, Maze I, Laplant QC et al.: Antidepressant actions of histone deacetylase inhibitors. J. Neurosci. 29(37), 11451-11460 (2009).
84. Szyf M, Weaver IC, Champagne FA, Diorio J, Meaney MJ: Maternal programming of steroid receptor expression and phenotype through DNA methylation in the rat. Front. Neuroendocrinol. 26(3-4), 139-162 (2005).
85. Weaver IC, Cervoni N, Champagne FA et al.: Epigenetic programming by maternal behavior. Nat. Neurosci. 7(8), 847-854 (2004).
86. Papakostas GI: Evidence for S-adenosyl-l-methionine (SAM-e) for the treatment of major depressive disorder. J. Clin. Psychiatry 70(Suppl. 5), 18-22 (2009).
87. Coppen A, Bolander-Gouaille C: Treatment of depression: time to consider folic acid and vitamin B12. J. Psychopharmacol. 19(1), 59-65 (2005).
88. Taylor MJ, Carney SM, Goodwin GM, Geddes JR: Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials. J. Psychopharmacol. 18(2), 251-256 (2004).
89. Pogribny IP, James SJ, Jernigan S, Pogribna M: Genomic hypomethylation is specific for preneoplastic liver in folate/methyl deficient rats and does not occur in non-target tissues. Mutat. Res. 548(1-2), 53-59 (2004).
90. Weaver IC, Champagne FA, Brown SE et al.: Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J. Neurosci. 25(47), 11045-11054 (2005).
91. Weaver IC, Meaney MJ, Szyf M: Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proc. Natl Acad. Sci. USA 103(9), 3480-3485 (2006).
92. Bottiglieri T: S-adenosyl-l-methionine (SAMe): from the bench to the bedside - molecular basis of a pleiotrophic molecule. Am. J. Clin. Nutr. 76(5), 1151-1157 (2002).
93. Eden A, Gaudet F, Waghmare A, Jaenisch R: Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300(5618), 455 (2003).
94. Brueckner B, Garcia Boy R, Siedlecki P et al.: Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. Cancer Res. 65(14), 6305-6311 (2005).
95. Perisic T, Zimmermann N, Kirmeier T et al.: Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes. Neuropsychopharmacology 35(3), 792-805 (2010).
96. Cassel S, Carouge D, Gensburger C et al.: Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol. Pharmacol. 70(2), 487-492 (2006).
97. Hunter RG, McCarthy KJ, Milne TA, Pfaff DW, McEwen BS: Regulation of hippocampal H3 histone methylation by acute and chronic stress. Proc. Natl Acad. Sci. USA 106(49), 20912-20917 (2009).
98. Göttlicher M, Minucci S, Zhu P et al.: Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 20(24), 6969-6978 (2001).